Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices

Background: In Europe, off-patent biologicals and biosimilars are largely procured by means of tender procedures. The organization and design of tenders may play a key role in the evolving biosimilar market, and currently, it is not fully elucidated how tenders for off-patent biologicals and biosimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Liese, Simoens, Steven, Soontjens, Caroline, Claus, Barbara, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225063/
https://www.ncbi.nlm.nih.gov/pubmed/34073861
http://dx.doi.org/10.3390/ph14060499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225063/
https://www.ncbi.nlm.nih.gov/pubmed/34073861
http://dx.doi.org/10.3390/ph14060499

Ejemplares similares